News Stories

Study to examine whether meditation techniques reduce stress and enhance the well-being of breast cancer survivors.

Dr, Joe "Skip" Garcia

A number of UA Cancer Center members will help shape the future success and growth of the Arizona Health Sciences Center as members of four advisory councils.

Emmanuelle J. Meuillet, PhD (left); Joseph Kobes

A new drug that is being researched at the University of Arizona Cancer Center aimed at pancreatic tumors may be delivered more effectively by being encapsulated by nanoparticles.

Yves A. Lussier, MD, FAMCI

Yves A. Lussier, MD, FAMCI, a professional engineer and physician-scientist who conducts research in translational bioinformatics and personal genomics, has joined the University of Arizona Cancer Center.

Thomas P. Miller, MD

Thomas P. Miller, MD, has been named the director of the Division of Hematology/Oncology in the UA College of Medicine’s Department of Medicine.

The UACC's Skin Cancer Institute's fourth annual Melanoma Walk set attendance and donation records as more than 400 people hit the street in support of melanoma research, outreach, education and patient care.

Gregory Rogers, PhD

University of Arizona Cancer Center member Gregory Rogers, PhD, has recently published a paper in the journal Current Biology, highlighting his laboratory’s innovative work exploring the link between the Polo-like kinase 4 (Plk4) protein levels and chromosomal instability (CIN), which can contribute to the formation of cancer.

Dr. Terry A. Badger

UA Cancer Center member Terry A. Badger, PhD, RN, PMHCNS-BC, FAAN, is leading a research study to evaluate the impact of low cost telephone-delivered counseling on quality of life for Latinas with breast cancer.

Donato Romagnolo, PhD, MSc

University of Arizona Cancer Center member Donato Romagnolo, PhD, MSc, is leading a study that suggests that external environmental and dietary factors in pregnant women may have an impact on future breast cancer risk for the offspring.

Joyce Schroeder, PhD, & Todd Camenisch, PhD

Joyce Schroeder, PhD, and Todd D. Camenisch, PhD, were recently awarded a grant from the National Cancer Institute to further develop a drug to treat metastatic breast cancer.